International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease – GlobeNewswire (press release)
Washington University School of Medicine in St. Louis |
International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease
GlobeNewswire (press release) CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two … Stem cells derived from eggs alone – study Human skin cells transformed directly into motor neurons Product News: Improved Stem Cell Growth Performance with Xeno-Free Cell Culture Medium |
